MAPT and Parkinson disease: Further, our model identified increased anti-Tau IgG1 levels in PD compared to MSA [F(4, 125) = 5.0, p = 9.0E-04], also only described by group (p = 1.0E-03) with decreased levels in MSA compared to PD (p = 0.022; Figure S1).